Generex Biotechnology Corporation - Financial and Strategic Analysis Review

Generex Biotechnology Corporation - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “Generex Biotechnology Corporation - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Generex Biotechnology Corporation The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Generex Biotechnology Corporation (Generex) is engaged in the research, development, manufacturing and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large molecules in the areas of diabetes, pain management and cancers. It has proprietary and proven advanced technology platform including buccal delivery technology and immunomedicines for the administration of formulations of large molecule drugs to the oral cavity. It has licensing and distribution agreements with many big companies to sell its products worldwide. The company has its operations in the US, Canada, Dubai and Bermuda.

Recent Developments

Sep 10, 2009: FDA Grants Approval For Generex Oral-lyn
Oct 14, 2009: Generex' Oral-lyn Receives FDA Price Approval Under Treatment IND Program
Oct 16, 2009: Generex Launches Generex Oral-lyn In Algeria

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.